9783540432296 - recent advances in glucocorticoid receptor action (ernst schering foundation symposium proceedings, band 40) (4 Ergebnisse)
Sprache: Englisch
Verlag: Springer-Verlag Berlin and Heidelberg GmbH & Co. K - 2002
- Hardcover
Anbieter: Bahamut Media, Reading, , Vereinigtes KönigreichBahamut Media
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Gut
EUR 4,92
EUR 8,04 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
hardcover. Zustand: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
- Hardcover
Anbieter: Book Broker, Berlin, , DeutschlandBook Broker
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 7,68
EUR 36,80 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Zustand: Wie neu. 2002. 401 S. Alle Bücher & Medienartikel von Book Broker sind stets in gutem & sehr gutem gebrauchsfähigen Zustand. Dieser Artikel weist folgende Merkmale auf: Helle/saubere Seiten in fester Bindung. Sprache: Englisch Gewicht in Gramm: 813 Gebundene Ausgabe, Maße: 14.61 cm x 1.91 cm x 20.32 cm.
- Hardcover
Anbieter: Buchpark, Trebbin, , DeutschlandBuchpark
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Sehr gut
EUR 7,69
EUR 105,00 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 408 | Sprache: Englisch | Produktart: Bücher | Since 1948, hydrocortisone (cortisol), the principal glucocorticoid (GC) of the human adrenal cortex has been successfully used at phar macological concentrations for the suppression of clinical manifesta tions of rheumatoid arthritis…. Numerous compounds with GC activity have also been developed and used. Fifty years after their initial clinical use, GCs are still the most im portant and frequently prescribed class of anti-inflammatory drugs for various inflammatory disorders. They are administered either orally, parenterally (intravenous, intramuscular, intrathecal), or topically (cu taneous, intranasal, pulmonic, rectal). Despite the many beneficial ef fects of GCs, they also have their limitations and disadvantages that occur with varying prevalence on different organs and after different durations of therapy. These side-effects can range in severity from cos metic (e.g. telangiectasias, hypertrichosis) to seriously disabling (e.g. induction of glaucoma, diabetes, osteoporosis) or even life-threatening disorders (e.g. gastric haemorrhage). These adverse effects of GCs se riously handicap their successful use as anti-inflammatory agents. There is therefore a strong need for the development of substances with the anti-inflammatory potency of classical GCs but with reduced side-effects.
- Hardcover
Anbieter: CSG Onlinebuch GMBH, Darmstadt, , DeutschlandCSG Onlinebuch GMBH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Sehr gut
EUR 24,61
EUR 95,00 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Gebunden. Zustand: Sehr gut. Gebraucht - Sehr gut Zustand: Sehr gut, Reihe: Ernst Schering Research Foundation Workshop , Band 40 XXI, 380 p. 82 illus., 10 in color. About this book The long-term use of glucocorticoids is associated with several deleterious effects. Attempts to separate the beneficial from the adverse effects of… these compounds have met with varying degrees of difficulty. The discovery of distinct modes of action of the glucocorticoid receptor, the protein that mediates glucocorticoid action has opened up many possibilities for improving glucocorticoid therapy. This book provides an in-depth overview of the molecular actions of the glucocorticoid receptor and discusses the chances of an imminent identification of selective glucocorticoid agonists. Such componds should fulfill all the criteria of a glucocorticoid but should lack the sideeffects so far linked with classical glucocorticoids. Written for scientists and researchers in molecular medicine.
